PaloBiofarma: Funding, Investors & Team (Sep 2026)
Palobiofarma is a Spanish Biotech company located in Barcelona’s Science Park. Our mission is to discover and develop new drugs based on the modulation of the adenosine receptors. Our vision is to be the first european adenosine drug discovery company
PaloBiofarma has raised $7.6M across 2 funding rounds on record, the most recent an undisclosed round of $7.6M announced in Feb 2024.
That round is in line with the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
PaloBiofarma Company Profile and Key Stats
Latest funding round on record: Feb 2024.
PaloBiofarma Funding Rounds
1 of 2 rounds was announced without a disclosed amount and is excluded from the total.
PaloBiofarma announced an undisclosed round in May 2023; the amount was not disclosed.
9 months later, an undisclosed round of $7.6M was announced in Feb 2024.
PaloBiofarma Founders and Leadership Team
Contact details for the PaloBiofarma team: 1 of 2 have an email address on file.
Start 14-day free trial →PaloBiofarma Funding Compared to Other Biotechnology Startups
PaloBiofarma's latest round of $7.6M is in line with the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like PaloBiofarma in Biotechnology and Barcelona
Companies Similar to PaloBiofarma
iPremom is a healthcare technology company that develops molecular diagnostic solutions for the early…
Gate2Brain is a biotech company focused on the development of therapeutics that efficiently cross biological…
Ona Therapeutics is a biotech company that specializes in the discovery and development of therapeutic…
IMPETUX develops and markets patented technology to characterise the mechanical properties of living tissues…
Molecular Gate refer to an innovative class of small-molecule drugs developed by Gate Bioscience. These drugs…
Modern medicine fails because it studies life in static environments. 60Nd revolutionizes the field with…
Devicare designs point-of-care medical devices that monitor, diagnose and treat chronic diseases. The…
Universal Diagnostics S.A. (UDX) is a company in Spain that specializes in in-vitro diagnostics. Their focus…
Phyture Biotech originated as a spin-off of the Faculty of Pharmacy at the University of Barcelona, founded…
Polimerbio offers sanitary product design and development based on biocompatible polymers, particularly…
Overture Life is a biotechnology company that specializes in developing automated technologies for assisted…
In order to cure diseases with unmet medical requirements, ARTHEx Biotech, a biotech business that was spun…
PaloBiofarma Funding FAQs
What does PaloBiofarma do?
Palobiofarma is a Spanish Biotech company located in Barcelona’s Science Park. Our mission is to discover and develop new drugs based on the modulation of the adenosine receptors. Our vision is to be the first european adenosine drug discovery company
How much funding has PaloBiofarma raised?
PaloBiofarma has raised $7.6M across 2 rounds on record. The most recent is an undisclosed round of $7.6M announced in Feb 2024.
When did PaloBiofarma last raise funding?
PaloBiofarma's most recent funding round on record is an undisclosed round of $7.6M, announced in Feb 2024.
Who founded PaloBiofarma?
FundedIQ lists Lyhen Gonzalez Lio (Founder) at PaloBiofarma.
Who is the CEO of PaloBiofarma?
Julio Castro is listed as CEO at PaloBiofarma.
Where is PaloBiofarma headquartered?
PaloBiofarma is based in Barcelona, Catalonia, Spain.
How many employees does PaloBiofarma have?
PaloBiofarma is in the 11-50 employee band.
How does PaloBiofarma's funding compare to other Biotechnology startups?
PaloBiofarma's latest round of $7.6M is in line with the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's PaloBiofarma Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for PaloBiofarma is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.